HBV PGRNA STATUS CAN REVEAL THE LONG-TERM PROGNOSES OF CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES

被引：0
|
作者：
Luo, Hao [1 ]
Tan, Ning [1 ]
Kang, Qian [1 ]
Pan, Jiali [1 ]
Xu, Xiaoyuan [2 ]
机构：
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
[2] Peking Univ, Hosp 1, Infect Dis, Beijing, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
651
引用
收藏
页码：408A / 408A
页数：1
相关论文
共 50 条
  • [31] Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Lane, Hsien-Yuan
    Chang, Chi-Yang
    Tai, Chi-Ming
    Tseng, Cheng-Hao
    Lo, Gin-Ho
    Perng, Daw-Shyong
    Lin, Jaw-Town
    Mo, Lein-Ray
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1920 - 1927
  • [32] Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
    Roade, Luisa
    Riveiro-Barciela, Mar
    Esteban, Rafael
    Buti, Maria
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [33] Long-term results of chronic hepatitis B antiviral treatment with nucleos(t)ide analogues: a single center experience
    Caviglia, Gian P.
    Olivero, Antonella
    Ngatchou, Doriane
    Saracco, Giorgio M.
    Smedile, Antonina
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (01) : 77 - 78
  • [34] Viral response in long-term therapy with nucleos(t)ide analogues in chronic hepatitis B cirrhosis prevents decompensation
    Carey, Ivana
    Knighton, Sarah
    Joshi, Deepak
    Barnabas, Ashley
    Verma, Suman
    Harrison, Phillip M.
    Suddle, Abid
    Agarwal, Kosh
    HEPATOLOGY, 2013, 58 : 666A - 666A
  • [35] HCC onset and features among chronic hepatitis B patients treated with nucleos(t)ide analogues
    Schranz, M.
    De Giorgio, M.
    Conte, G.
    Pasulo, L.
    Magini, G.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E66 - E66
  • [36] LONG-TERM OUTCOMES AFTER NUCLEOS(T)IDE ANALOGUES DISCONTINUATION IN CHRONIC HEPATITIS B PATIENTS WHO ARE HBeAg-POSITIVE
    He, D.
    Tao, S.
    Guo, S.
    Wang, Y.
    Ding, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S443 - S443
  • [37] Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Deutsch, Melanie-Maria
    Triantos, Christos
    Tsolias, Chrysostomos
    Manesis, Emanuel K.
    Mathou, Nicoletta
    Alexopoulou, Alexandra
    Hadziyannis, Emilia
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2021, 41 (01) : 48 - 57
  • [38] Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B
    Maier, Melanie
    Liebert, Uwe G.
    Wittekind, Christian
    Kaiser, Thorsten
    Berg, Thomas
    Wiegand, Johannes
    PLOS ONE, 2013, 8 (06):
  • [39] Short-term response and safety of nucleos(t)ide analogues in patients with chronic hepatitis B
    Mateos, M.
    Elberdin, L.
    Ramudo, L.
    Cid, P.
    Margusino, L.
    Martin, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 978 - 979
  • [40] LONG TERM NUCLEOS(T)IDE ANALOGUE THERAPY REDUCED THE EXTENT OF HBV DNA INTEGRATION IN CHRONIC HEPATITIS B PATIENTS
    Chow, Ning
    Wong, Danny Ka-Ho
    Mak, Lung Yi
    Fung, James
    Seto, Wai Kay Walter
    Lai, Ching Lung
    Yuen, Man Fung
    HEPATOLOGY, 2020, 72 : 19A - 19A
12345